Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Interleukin-2 (aldesleukin).
Locations
3
United States
Boston Children's Hospital
Boston, Massachusetts, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Mount Sinai
New York, New York, United States
Start Date
March 11, 2021
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2027
Last Updated
February 3, 2026
NCT05421455
NCT07245394
NCT07089420
NCT05698745
NCT06953791
NCT06896305
Lead Sponsor
Boston Children's Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions